Average Co-Inventor Count = 10.10
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (9 from 1,777 patents)
2. Transtech Pharma, Inc. (9 from 49 patents)
3. Vtv Therapeutics LLC (1 from 52 patents)
19 patents:
1. 9162963 - Phenylglyoxylic acid derivatives and their preparation and use
2. 8987295 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
3. 8933222 - Oxadiazoanthracene compounds for the treatment of diabetes
4. RE45183 - Heteroaryl-ureas and their use as glucokinase activators
5. 8703766 - Oxadiazoanthracene compounds for the treatment of diabetes
6. 8524708 - Oxadiazoanthracene compounds for the treatment of diabetes
7. 8383644 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
8. 8263634 - Heteroaryl-ureas and their use as glucokinase activators
9. 8211925 - Benzamide glucokinase activators
10. 8063081 - Aryl carbonyl derivatives as therapeutic agents
11. 7906507 - Oxadiazoanthracene compounds for the treatment of diabetes
12. 7897628 - Aryl carbonyl derivatives as therapeutic agents
13. 7872139 - Heteroaryl-ureas and their use as glucokinase activators
14. 7851636 - Heteroaryl-ureas and their use as glucokinase activators
15. 7790714 - Oxadiazoanthracene compounds for the treatment of diabetes